相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease
Francesco Boin et al.
ARTHRITIS AND RHEUMATISM (2008)
Soluble CD30 levels as a diagnostic marker for bronchiolitis obliterans syndrome following human lung transplantation
Anjali S. Golocheikine et al.
TRANSPLANT IMMUNOLOGY (2008)
A phase 1 multidose study of SGN-30 immunotherapy in patients with refractory or recurrent CD30+ hematologic malignancies
Nancy L. Bartlett et al.
BLOOD (2008)
Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30
Ezogelin Oflazoglu et al.
BLOOD (2007)
Rituximab-induced interstitial lung disease
Stephanie A. Wagner et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804
N. L. Bartlett et al.
ANNALS OF ONCOLOGY (2007)
Activated T cell subsets in human type 1 diabetes:: evidence for expansion of the DR+ CD30+ subpopulation in new-onset disease
C. Baker et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2007)
Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease
Robert Zeiser et al.
BLOOD (2007)
Revised response criteria for malignant lymphoma
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma
Armando Santoro et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Phase Ia/Ib chemo-radiation trial of gemcitabine and dose-escalated thoracic radiation in patients with stage III A/B non-small cell lung cancer
A. William Blackstock et al.
JOURNAL OF THORACIC ONCOLOGY (2006)
Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation
AM Bauwens et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma
J Kuruvilla et al.
CANCER (2006)
Pulmonary T(H)2 response in Pseudomonas aeruginos-infected patients with cystic fibrosis
D Hartl et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2006)
Deciphering CD30 ligand biology and its role in humoral immunity
Mary K. Kennedy et al.
IMMUNOLOGY (2006)
Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics
CG Cerveny et al.
LEUKEMIA (2005)
CD8+ T lymphocytes in lung tissue from patients with idiopathic pulmonary fibrosis -: art. no. 81
Z Daniil et al.
RESPIRATORY RESEARCH (2005)
Combination of the human anti-CD30 antibody 5F11 with cytostatic drugs enhances its antitumor activity against Hodgkin and anaplastic large cell lymphoma cell lines
F Heuck et al.
JOURNAL OF IMMUNOTHERAPY (2004)
From the bench to the bedside: ways to improve rituximab efficacy
G Cartron et al.
BLOOD (2004)
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination of gemcitabine and bleomycin:: A report of the German Hodgkin's lymphoma Study Group
H Bredenfeld et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease
JW Friedberg et al.
CANCER (2003)
Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma
WK Weng et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
A report on serious pulmonary toxicity associated with gemcitabine-based therapy
DF Roychowdhury et al.
INVESTIGATIONAL NEW DRUGS (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Gemcitabine-induced pulmonary toxicity - Case report and review of the literature
N Gupta et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2002)
分享论文
